# Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions

> **NCT00830349** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Risperidone
- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00830349
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2001-07
- **Final completion:** 2004-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00830349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00830349, "Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00830349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*